Drawing for MININEPH PLUS

USPTO serial 77670838

MININEPH PLUS

Reviewed by CopyMark Law Group

Reg. 3871081Status 710
Filing date
Status date
Registration date
Nov 2, 2010
Examiner
EULIN, INGRID C
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with MININEPH PLUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jay H. Geller

12100 Wilshire Bl., Suite 500Los Angeles, CA 90025-7121UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic kits comprised of diagnostic reagents for laboratory use, calibrators, reagent plates, buffered solutions, diluent solutions, and serum; Reagents, diagnostic reagents, biological reagents, histology reagents, enzyme immunoassay reagents, antigen substrates, and antibodies for scientific research use; and test kits comprised of reagents, buffers, calibrators, diluents, antibodies, antigen substrates, conjugates, stopping solutions, antisera and/or dropper bottles for scientific and research use using blood, body fluids, body tissues or extracts thereof; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Chemicals, namely, buffer and standard solutions used in analytical chemistry; Diagnostic preparations for scientific or research use; Diagnostic preparations for scientific use; Diagnostic preparations used in science; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Reagents for chemical analyses; Reagents for research purposes; Reagents for scientific or medical research use; Reagents for use in scientific apparatus for chemical or biological analysisSECTION 8 - CANCELLEDMay 20, 2010
005Calibrating solutions, diluents, control samples, reagents, antibodies, antigen substrates, conjugates, stopping solutions, histology reagents, enzyme immunoassay reagents and general purpose reagents for medical and veterinary diagnostic and clinical use; and diagnostic and immunological test kits consisting of reagents, controls, buffers, calibrators, diluents, antibodies, antigen substrates, conjugates, stopping solutions, antisera and/or dropper bottles, all for use in measuring the concentration of proteins, antibodies, antigens and other substances in blood, other body fluids and body tissues, or extracts thereof, for use in the diagnosis, treatment, cure, prevention or mitigation of diseases and other conditions in humans and animals; biological and chemical preparations and reagents for medical or veterinary use; Clinical medical reagents; Diagnostic preparations for clinical or medical laboratory use; Diagnostic preparations for medical and veterinary use; Diagnostic reagents for medicinal use; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing of body fluids; Reagents and media for medical and veterinary diagnostic purposes; Reagents for medical use; medical diagnostic kits for use in immunology and serology, consisting primarily of extracts from blood or body fluids; control solutions indicative of a positive result for medical use; buffer solutions for diluting samples and/or reagents for medical use; reagents, blood reagents; antisera for precipitating specific proteins, for medical purposes; fixative for precipitating proteins, for medical purposes; templates for controlling the application of samples and/or antisera, for medical purposesSECTION 8 - CANCELLEDMay 20, 2010
009Computer software for use in data manipulation and instrument control for use in measuring the concentration of proteins, antibodies, antigens and other substances in body fluids for use in the diagnosis, treatment, prevention, cure and mitigation of diseases and other conditions in humans; and nephelometers for use in measuring the concentration of proteins, antibodies, antigens and other substances in body fluids for use in the diagnosis, treatment, prevention, cure and mitigation of diseases and other conditions in humansSECTION 8 - CANCELLEDMay 20, 2010
010Medical diagnostic apparatus and instruments for the diagnosis, treatment and cure of diseases in humans, namely, multiple myeloma, lymphocytic neoplasms, Waldenstrom's macroglobulinemia, amyloidosis, light chain deposition diseases and connective tissues diseases, namely, systemic lupus erythematosus; apparatus for blood, urine and serum analysis; apparatus for clinical diagnosis; apparatus used in implementing diagnostic tests designed to detect abnormalities in blood, serum and urine, namely, automated clinical analyzers; and medical diagnostic apparatus and analytical apparatus for medical purposesSECTION 8 - CANCELLEDMay 20, 2010

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 9, 2017C8..CANCELLED SEC. 8 (6-YR)
Mar 15, 2011CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 15, 2011COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 2, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 25, 2010SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 24, 2010REGVLAW OFFICE REGISTRATION REVIEW COMPLETED
Sep 23, 2010CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 22, 2010SUPCSTATEMENT OF USE PROCESSING COMPLETE
Sep 22, 2010AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 24, 2010IUAFUSE AMENDMENT FILED
Aug 24, 2010EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 11, 2010EX1GSOU EXTENSION 1 GRANTED
Feb 11, 2010EXT1SOU EXTENSION 1 FILED
Feb 11, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 1, 2009NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 28, 2009TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 8, 2009ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jun 9, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 20, 2009NPUBNOTICE OF PUBLICATION
May 6, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
May 6, 2009ALIEASSIGNED TO LIE
May 6, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
May 6, 2009DOCKASSIGNED TO EXAMINER
Feb 18, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 18, 2009NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance